IMMUNE NETWORK

  • 제4권3호
  • /
  • Pages.184-189
  • /
  • 2004
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지

TNF-${\alpha}$ Up-regulated the Expression of HuR, a Prognostic Marker for Ovarian Cancer and Hu Syndrome, in BJAB Cells

  • Lee, Kyung-Yeol (Division of Biological Sciences, Chonbuk National University College of Natural Sciences)
  • 발행 : 2004.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Hu syndrome, a neurological disorder, is characterized by the remote effect of small cell lung cancer on the neural degeneration. The suspicious effectors for this disease are anti-Hu autoantibodies or Hu-related CD8+ T lymphocytes. Interestingly, the same effectors have been suggested to act against tumor growth and this phenomenon may represent natural tumor immunity. For these diagnostic and therapeutic reasons, the demand for antibodies against Hu protein is rapidly growing. Methods: Polyclonal and monoclonal antibodies were generated using recombinant HuR protein. Western blot analyses were performed to check the specificity of generated antibodies using various recombinant proteins and cell lysates. Extracellular stimuli for HuR expression had been searched and HuR-associated proteins were isolated from polysome lysates and then separated in a 2-dimensional gel. Results: Polyclonal and monoclonal antibodies against HuR protein were generated and these antibodies showed HuR specificity. Antibodies were also useful to detect and immunoprecipitate endogenous HuR protein in Jurkat and BJAB. This report also revealed that TNF-${\alpha}$ treatment in BJAB up-regulated HuR expression. Lastly, protein profile in HuR-associated mRNAprotein complexes was mapped by 2-dimensional gel electrophoresis. Conclusion: This study reported that new antibodies against HuR protein were successfully generated. Currently, project to develop a diagnostic kit is in process. Also, this report showed that TNF-${\alpha}$ up-regulated HuR expression in BJAB and protein profile associated with HuR protein was mapped.

키워드

과제정보

연구 과제 주관 기관 : Chonbuk National University

참고문헌

  1. Albert ML, Darnell RB: Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4;36-44, 2004 https://doi.org/10.1038/nrc1255
  2. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 349;1543-1554, 2003 https://doi.org/10.1056/NEJMra023009
  3. Darnell RB: Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 61;30-32, 2004 https://doi.org/10.1001/archneur.61.1.30
  4. Musunuru K, Darnell RB: Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci 24;239-262, 2001 https://doi.org/10.1146/annurev.neuro.24.1.239
  5. Dalmau J, Graus F, Rosenblum MK, Posner JB: Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 71;59-72, 1992 https://doi.org/10.1097/00005792-199203000-00001
  6. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY: Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124;1138-1148, 2001 https://doi.org/10.1093/brain/124.6.1138
  7. Denkert C, Weichert W, Pest S, Koch I, Licht D, Kobel M, Reles A, Sehouli J, Dietel M, Hauptmann S: Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64;189-195, 2004 https://doi.org/10.1158/0008-5472.CAN-03-1987
  8. Dalmau J, Gultekin HS, Posner JB: Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 9;275-284, 1999 https://doi.org/10.1111/j.1750-3639.1999.tb00226.x
  9. Sutton I, Winer JB: The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci 102;475-486, 2002 https://doi.org/10.1042/CS20010121
  10. Dalmau J, Graus F, Cheung NK, Rosenblum MK, Ho A, Canete A, Delattre JY, Thompson SJ, Posner JB: Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75;99-109, 1995 https://doi.org/10.1002/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I
  11. Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, Vincent A, Vedeler CA: Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol 22;795-800, 2004 https://doi.org/10.1200/JCO.2004.01.028
  12. Chung S, Jiang L, Cheng S, Furneaux H: Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem 271;11518-11524, 1996 https://doi.org/10.1074/jbc.271.19.11518
  13. Levine TD, Gao F, King PH, Andrews LG, Keene JD: Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol 13;3494-3504, 1993 https://doi.org/10.1128/MCB.13.6.3494
  14. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271;8144-8151, 1996 https://doi.org/10.1074/jbc.271.14.8144
  15. Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A: Posttranscriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195;356-372, 2003 https://doi.org/10.1002/jcp.10272
  16. Chen CY, Shyu AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20;465-470, 1995 https://doi.org/10.1016/S0968-0004(00)89102-1
  17. Guhaniyogi J, Brewer G: Regulation of mRNA stability in mammalian cells. Gene 265;11-23, 2001 https://doi.org/10.1016/S0378-1119(01)00350-X
  18. Mignone F, Gissi C, Liuni S, Pesole G: Untranslated regions of mRNAs. Genome Biol 3;reviews0004.1-0004.10, 2002
  19. Shaw G, Kamen R: A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46;659-667, 1986 https://doi.org/10.1016/0092-8674(86)90341-7
  20. Shim J, Karin M: The control of mRNA stability in response to extracellular stimuli. Mol Cells 14;323-331, 2002
  21. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS: ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29;246-254, 2001 https://doi.org/10.1093/nar/29.1.246
  22. Blackshear PJ: Tristetraprolin and other CCCH tandem zincfinger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30;945-952, 2002 https://doi.org/10.1042/BST0300945
  23. Brennan CM, Steitz JA: HuR and mRNA stability. Cell Mol Life Sci 58;266-277, 2001 https://doi.org/10.1007/PL00000854
  24. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, Karin M: AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107;451-464, 2001 https://doi.org/10.1016/S0092-8674(01)00578-5
  25. Gherzi R, Lee KY, Briata P, Wegmuller D, Moroni C, Karin M, Chen CY: A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 14;571-583, 2004 https://doi.org/10.1016/j.molcel.2004.05.002
  26. Sarkar B, Xi Q, He C, Schneider RJ: Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol 23;6685-6693, 2003 https://doi.org/10.1128/MCB.23.18.6685-6693.2003
  27. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M, Gross B, Lu M, Kitamura T, Moroni C: Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J 21;4709-4718, 2002 https://doi.org/10.1093/emboj/cdf444
  28. Wilson GM, Brewer G: The search for trans-acting factors controlling messenger RNA decay. Prog Nucleic Acid Res Mol Biol 62:257-91.;257-291, 1999
  29. Keene JD, Tenenbaum SA: Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9;1161-1167, 2002 https://doi.org/10.1016/S1097-2765(02)00559-2
  30. Tenenbaum SA, Carson CC, Lager PJ, Keene JD: Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci USA 97;14085-14090, 2000 https://doi.org/10.1073/pnas.97.26.14085
  31. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST: Microarray identification of FMRPassociated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107;477-487, 2001 https://doi.org/10.1016/S0092-8674(01)00568-2
  32. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB: Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107;489-499, 2001 https://doi.org/10.1016/S0092-8674(01)00566-9
  33. Lopez dS, I, Zhan M, Lal A, Yang X, Gorospe M: Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101;2987-2992, 2004 https://doi.org/10.1073/pnas.0306453101
  34. Wu Z, Wu J, Jacinto E, Karin M: Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol Cell Biol 17;7407-7416, 1997 https://doi.org/10.1128/MCB.17.12.7407
  35. Tenenbaum SA, Lager PJ, Carson CC, Keene JD: Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26;191-198, 2002 https://doi.org/10.1016/S1046-2023(02)00022-1
  36. Fan XC, Steitz JA: Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17;3448-3460, 1998 https://doi.org/10.1093/emboj/17.12.3448
  37. Ford LP, Watson J, Keene JD, Wilusz J: ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13;188-201, 1999 https://doi.org/10.1101/gad.13.2.188
  38. Peng SS, Chen CY, Xu N, Shyu AB: RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17;3461-3470, 1998 https://doi.org/10.1093/emboj/17.12.3461
  39. Tenenbaum SA, Carson CC, Atasoy U, Keene JD: Genomewide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera. Gene 317;79-87, 2003 https://doi.org/10.1016/S0378-1119(03)00661-9